We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BIVI market cap is 20.13M. The company's latest EPS is USD -1.2605 and P/E is -0.39.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.5M | -13.77M | -10.98M | -10.88M | -8.78M |
| Net Income | -15.69M | -15.04M | -9.11M | -10.71M | -8.4M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.5M | -2.69M | -138.05M | -27.25M | -45.08M |
| Net Income | -2.49M | -33.78M | -183.85M | -26.08M | -50.26M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 47.19M | 45.18M | 35.11M | 23.76M | 21.49M |
| Total Liabilities | 21.12M | 23.47M | 19.77M | 16.21M | 14M |
| Total Equity | 26.07M | 21.72M | 15.34M | 7.55M | 7.49M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.57M | 2.08M | 6.05M | 20.12M | 35.11M |
| Total Liabilities | 443k | 23.58M | 996k | 16.44M | 19.77M |
| Total Equity | 2.13M | -21.5M | 5.05M | 3.67M | 15.34M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.23M | -28.97M | -40.25M | -12.18M | -18.09M |
| Investing | N/A | -12.51M | -14.3M | 14.53M | 14.53M |
| Financing | 44.34M | 54.11M | 55.37M | -594k | 4.33M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.5M | -1.63M | -10.45M | -18.99M | -40.25M |
| Investing | N/A | N/A | N/A | N/A | -14.3M |
| Financing | 2.8M | 1.33M | 14.93M | 33.12M | 55.37M |
| Market Cap | 20.13M |
| Price to Earnings Ratio | -0.39 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1 |
| Price to Book Ratio | 1.27 |
| Dividend Yield | - |
| Shares Outstanding | 39.87M |
| Average Volume (1 week) | 541.57k |
| Average Volume (1 Month) | 772.53k |
| 52 Week Change | -93.17% |
| 52 Week High | 8.69 |
| 52 Week Low | 0.445 |
| Spread (Intraday) | 0.33 (41.92%) |
| Company Name | BioVie Inc |
| Address |
701 s. carson street carson city, nevada 89701 |
| Website | https://www.bioviepharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
